The Library
Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredients
Tools
Tools
Tools
Furner-Pardoe, Jessica, Anonye, Blessing O., Cain, Ricky, Moat, John, Ortori, Catherine A., Lee, Christina, Barrett, David A., Corre, Christophe and Harrison, Freya (2020) Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredients. Scientific Reports, 10 (1). 12687. doi:10.1038/s41598-020-69273-8 ISSN 2045-2322.
|
PDF
WRAP-anti-biofilm-efficacy-medieval-treatment-bacterial-infection-requires-combination-multiple-ingredients-Harrison-2020.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (1831Kb) | Preview |
Official URL: http://dx.doi.org/10.1038/s41598-020-69273-8
Abstract
Novel antimicrobials are urgently needed to combat drug-resistant bacteria and to overcome the inherent difficulties in treating biofilm-associated infections. Studying plants and other natural materials used in historical infection remedies may enable further discoveries to help fill the antibiotic discovery gap. We previously reconstructed a 1,000-year-old remedy containing onion, garlic, wine, and bile salts, known as ‘Bald’s eyesalve’, and showed it had promising antibacterial activity. In this current paper, we have found this bactericidal activity extends to a range of Gram-negative and Gram-positive wound pathogens in planktonic culture and, crucially, that this activity is maintained against Acinetobacter baumannii, Stenotrophomonas maltophilia, Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus pyogenes in a soft-tissue wound biofilm model. While the presence of garlic in the mixture can explain the activity against planktonic cultures, garlic has no activity against biofilms. We have found the potent anti-biofilm activity of Bald’s eyesalve cannot be attributed to a single ingredient and requires the combination of all ingredients to achieve full activity. Our work highlights the need to explore not only single compounds but also mixtures of natural products for treating biofilm infections and underlines the importance of working with biofilm models when exploring natural products for the anti-biofilm pipeline.
| Item Type: | Journal Article | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QR Microbiology R Medicine > RM Therapeutics. Pharmacology |
|||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
|||||||||
| Library of Congress Subject Headings (LCSH): | Biofilms, Bacterial diseases, Bacterial diseases -- Treatment, Anti-infective agents | |||||||||
| Journal or Publication Title: | Scientific Reports | |||||||||
| Publisher: | Nature Publishing Group | |||||||||
| ISSN: | 2045-2322 | |||||||||
| Official Date: | 28 July 2020 | |||||||||
| Dates: |
|
|||||||||
| Volume: | 10 | |||||||||
| Number: | 1 | |||||||||
| Article Number: | 12687 | |||||||||
| DOI: | 10.1038/s41598-020-69273-8 | |||||||||
| Status: | Peer Reviewed | |||||||||
| Publication Status: | Published | |||||||||
| Access rights to Published version: | Open Access (Creative Commons) | |||||||||
| Date of first compliant deposit: | 6 August 2020 | |||||||||
| Date of first compliant Open Access: | 6 August 2020 | |||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
